Delivery Order SPE2DB24D3014-SPE2DB25FKTQL

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $45K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML medication. The contract has a firm fixed price, with a ceiling value of $18,395.93, and runs through March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract is a firm-fixed price delivery order with a ceiling value of $47,103.62 and a completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is valued at $12,604.63 and has an ultimate completion date of February 4, 2025. The contract covers the provision of SKYRIZI 180 MG/1.2 ML ON-BODY 1.2ML, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a ceiling value of $14,530.01 and a completion date of June 4, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a firm fixed price ceiling value of $56,561.02 and a performance period ending on May 16, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. The contract has a ceiling value of $35,811.28 and a performance period ending on June 6, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML. The contract has a ceiling value of $12,604.63 and a completion date of May 20, 2025. Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML medication. The contract has a ceiling value of $43,686.89 and a period of performance through May 6, 2025. It is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $69,979.02, is for the supply of SKYRIZI 150 MG/ML PENML, a medication. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML, a medication. The award has a ceiling value of $13,833.13 and a period of performance through May 7, 2025. The contract is a Firm Fixed Price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB25FKTQL
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $44,673.02 and an ultimate completion date of June 6, 2025. It is for the delivery of SKYRIZI 150 MG/ML PENML, a pharmaceutical product.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order contract is not set-aside and allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/4/25, 10:02 AM